|
|
Volumn 10, Issue 4, 2015, Pages e16-e17
|
|
Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
CARBOPLATIN;
DENOSUMAB;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FLUORODEOXYGLUCOSE F 18;
PEMETREXED;
TRASTUZUMAB EMTANSINE;
ANTINEOPLASTIC AGENT;
DNA;
ERBB2 PROTEIN, HUMAN;
MAYTANSINE;
MONOCLONAL ANTIBODY;
ADULT;
BRAIN METASTASIS;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER STAGING;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE COURSE;
DRUG TOLERABILITY;
EMISSION TOMOGRAPHY;
FEMALE;
FOLLOW UP;
HEADACHE;
HEALTH INSURANCE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
INDUCTION CHEMOTHERAPY;
LUNG CANCER;
MIDDLE AGED;
NOTE;
PELVIC PAIN;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
TUMOR GROWTH;
ADENOCARCINOMA;
ANALOGS AND DERIVATIVES;
GENETICS;
LUNG NEOPLASMS;
METABOLISM;
MUTATION;
NUCLEIC ACID AMPLIFICATION;
POSITRON EMISSION TOMOGRAPHY;
ADENOCARCINOMA;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
DNA, NEOPLASM;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION;
LUNG NEOPLASMS;
MAYTANSINE;
MIDDLE AGED;
MUTATION;
NEOPLASM STAGING;
NUCLEIC ACID AMPLIFICATION TECHNIQUES;
POSITRON-EMISSION TOMOGRAPHY;
RECEPTOR, ERBB-2;
|
|
EID: 84938228586
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0000000000000424 Document Type: Article |
|
Times cited : (19)
|
|
References (5)
|
